BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7959286)

  • 1. Comparative studies of taxol and taxotere on tumor growth and lymphocyte functions.
    Munkarah A; Chuang L; Lotzová E; Cook K; Morris M; Wharton JT
    Gynecol Oncol; 1994 Nov; 55(2):211-6. PubMed ID: 7959286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol.
    Chuang LT; Lotzová E; Heath J; Cook KR; Munkarah A; Morris M; Wharton JT
    Cancer Res; 1994 Mar; 54(5):1286-91. PubMed ID: 7907000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cytotoxic activity of Taxol and Taxotere on primary cultures and established cell lines of human ovarian cancer.
    Silvestrini R; Zaffaroni N; Orlandi L; Oriana S
    Stem Cells; 1993 Nov; 11(6):528-35. PubMed ID: 7906583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of new investigational drug taxol on oncolytic activity and stimulation of human lymphocytes.
    Chuang LT; Lotzová E; Cook KR; Cristoforoni P; Morris M; Wharton JT
    Gynecol Oncol; 1993 Jun; 49(3):291-8. PubMed ID: 8100207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Kelland LR; Abel G
    Cancer Chemother Pharmacol; 1992; 30(6):444-50. PubMed ID: 1356649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells.
    Hanauske AR; Degen D; Hilsenbeck SG; Bissery MC; Von Hoff DD
    Anticancer Drugs; 1992 Apr; 3(2):121-4. PubMed ID: 1356030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
    Hennequin C; Giocanti N; Favaudon V
    Cancer Res; 1996 Apr; 56(8):1842-50. PubMed ID: 8620502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxotere inhibits in-vitro growth of human colonic cancer cell lines.
    Karantanis E; Nicholson S; Morris DL
    Eur J Surg Oncol; 1994 Dec; 20(6):653-7. PubMed ID: 7995417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxol and taxotere in bladder cancer: in vitro activity and urine stability.
    Rangel C; Niell H; Miller A; Cox C
    Cancer Chemother Pharmacol; 1994; 33(6):460-4. PubMed ID: 7907952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
    Braakhuis BJ; Hill BT; Dietel M; Kelland LR; Aapro MS; Zoli W; Lelieveld P
    Anticancer Res; 1994; 14(1A):205-8. PubMed ID: 7909419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis and cytotoxicity of the new taxoids].
    Yao F; Guo J; Liang X
    Yao Xue Xue Bao; 1998 Sep; 33(9):659-65. PubMed ID: 12016869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion.
    Bissett D; Setanoians A; Cassidy J; Graham MA; Chadwick GA; Wilson P; Auzannet V; Le Bail N; Kaye SB; Kerr DJ
    Cancer Res; 1993 Feb; 53(3):523-7. PubMed ID: 8093854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer.
    Lee LF; Schuerer-Maly CC; Lofquist AK; van Haaften-Day C; Ting JP; White CM; Martin BK; Haskill JS
    Cancer Res; 1996 Mar; 56(6):1303-8. PubMed ID: 8640818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the structural region of taxol that may be responsible for cytokine gene induction and cytotoxicity in human ovarian cancer cells.
    Watson JM; Kingston DG; Chordia MD; Chaudhary AG; Rinehart CA; Haskill JS
    Cancer Chemother Pharmacol; 1998; 41(5):391-7. PubMed ID: 9523735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere.
    Rosenblum MD; Shivers RR
    Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jan; 125(1):121-31. PubMed ID: 11790336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The scientific rationale for developing taxoids.
    Aapro M
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol.
    Yu D; Liu B; Jing T; Sun D; Price JE; Singletary SE; Ibrahim N; Hortobagyi GN; Hung MC
    Oncogene; 1998 Apr; 16(16):2087-94. PubMed ID: 9572489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer.
    Boven E; Venema-Gaberscek E; Erkelens CA; Bissery MC; Pinedo HM
    Ann Oncol; 1993 Apr; 4(4):321-4. PubMed ID: 8100146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Taxotere: from yew's needles to clinical practice].
    Lavelle F; Gueritte-Voegelein F; Guenard D
    Bull Cancer; 1993 Apr; 80(4):326-38. PubMed ID: 7909695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells.
    Boudny V; Nakano S
    Anticancer Res; 2003; 23(1A):7-12. PubMed ID: 12680188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.